InvestorsHub Logo
Followers 45
Posts 9536
Boards Moderated 0
Alias Born 07/14/2005

Re: BonelessCat post# 79431

Monday, 11/24/2014 11:11:03 AM

Monday, November 24, 2014 11:11:03 AM

Post# of 403558
BK,... would you please add some clarity to this part of the PR:


Looking to Brilacidin, the lead drug candidate in the Company’s definsin-mimetic platform, Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection. This potential prophylactic use was not part of Cellceutix’s strategic plans for Brilacidin, but given the compilation of clinical and laboratory data, it is a logical application that could potentially add millions of dollars of revenue to the Company. The material transfer does not cover the pharmaceutical use of Brilacidin for treatment of infections or other diseases. A final contract can only be entered into if and when Brilacidin receives Food and Drug Administration (FDA) approval.



Does that mean you you must clear the new use for B with the FDA before a contract with the Big Pharma can be inked,...? Any estimate on when you will be trying to get that approval and how long it might take,..?

Can anyone here confirm what exactly that means,...that APPROVAL from the FDA,...?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News